Operating Lease, Liability of Anika Therapeutics, Inc. from 31 Mar 2019 to 31 Dec 2025

Taxonomy & unit: us-gaap: USD
Description: Present value of lessee's discounted obligation for lease payments from operating lease.
Summary: Anika Therapeutics, Inc. quarterly Operating Lease, Liability in USD history and change rate from 31 Mar 2019 to 31 Dec 2025.
Anika Therapeutics, Inc. Operating Lease, Liability for the quarter ending 31 Dec 2025 was $26,248,000, a 1.2% increase year-over-year.
Source SEC data: View on sec.gov

Operating Lease, Liability, Quarterly (USD)

Operating Lease, Liability, YoY Quarterly Change (%)

Anika Therapeutics, Inc. Quarterly Operating Lease, Liability (USD)

Period	Value	YoY Chg	Change %	Date	Report	Filed	Fiscal Year	Fiscal Period
Q4 2025	$26,248,000	+$316,000	+1.2%	31 Dec 2025	10-K	03 Mar 2026	2025	FY
Q4 2024	$25,932,000			31 Dec 2024	10-K	17 Mar 2025	2024	FY
Q3 2019	$22,712,000			30 Sep 2019	10-Q	28 Oct 2019	2019	Q3
Q2 2019	$23,075,000			30 Jun 2019	10-Q	26 Jul 2019	2019	Q2
Q1 2019	$23,307,000			31 Mar 2019	10-Q	06 May 2019	2019	Q1

* An asterisk sign (*) next to the value indicates that the value is likely invalid.